Persistence rate with medical treatment in patients with idiopathic or neurogenic overactive bladder

Not Applicable

Completed

• Conditions: Overactive bladder; Urological and Genital Diseases; Other specified disorders of bladder

• Registration Number: ISRCTN13129226
• Lead Sponsor: Erasmus Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-03-17
• Last Update Posted: 22 May 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 123

Inclusion Criteria

1. Patients older than 18 years
2. Idiopathic or neurogenic overactive bladder
3. Newly prescribed solifenacin

Exclusion Criteria

1. Patients not on solifenacin
2. Patients who had used anticholinergic drugs less than 7 days before they started solifenacin

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Persistence of usage, measured by telephone surveys at 1, 3, 6 and 12 months

Secondary Outcome Measures

Name	Time	Method
Reasons for stopping medication, measured by telephone surveys at 1, 3, 6 and 12 months